openPR Logo
Press release

Discover the Growth of the Pulmonary edema Market 2019

12-27-2017 02:47 PM CET | Health & Medicine

Press release from: Transparency Market Research

Pulmonary edema is considered a leading cause of deaths among cardiovascular diseases. The global market for pulmonary edema is chiefly driven by the rising prevalence of cardiac attacks and other associated diseases, changing lifestyles of the global population, extensive research and development activities, and an increased awareness about preventive therapies.
 
The report on the global pulmonary edema market presents a detailed account of the various factors affecting the overall growth, factors restraining growth, trends, and other important factors shaping the market.

Obtain Report Details @ https://www.transparencymarketresearch.com/pulmonary-edema-market.html
 
Utilizing industry-leading research tools and techniques, the pulmonary edema market report serves as an excellent guide to market strategies, ensuring effective financial planning, investment modeling, expansion in new market segments, and monitoring the market’s competitive landscape. With the rising prevalence of cardiovascular diseases across the globe, the outlook for the markets for therapeutic methodologies, medicines, and other related markets pertaining to the field of cardiovascular diseases is promising.
 
Overview of the Global Pulmonary Edema Market
 
The WHO states that across the world, nearly 82% of the 38 million deaths caused by non-communicable diseases (NCDs) in 2012 were due to one of the following four NCDs - cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes. Of these, the leading cause of deaths was the segment of cardiovascular diseases, resulting in nearly 17.5 million deaths, or a 46.2% share of NCD deaths. 
 
A large portion of these deaths occurred due to pulmonary edema, a condition which leads to impaired gas exchange and may also lead to respiratory failure due to fluid accumulation in parenchyma and air spaces of lungs. A major causative agent responsible for pulmonary edema is the failure of the left ventricle of the heart, while an injury to the lungs is also a chief reason leading to the condition.

Make an Enquiry @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2250
 
The global market for pulmonary edema presents a detailed account of the chief diagnostic technologies, therapeutic methods, and key regional markets. Diagnostic technologies consist of ECG, x-ray, renal and liver function tests, and blood tests for electrolyte concentration. Therapeutic methods for pulmonary edema include emergency management techniques such as antibiotics for lung infection-induced pulmonary edema, natural or mechanical ventilation, respiratory distress agents such as morphine, antipyretics for minimizing pain, and loop diuretics.
 
While the global pulmonary edema market has huge growth prospects, it will have to face restraints such as the high cost required in R&D activities and government austerity towards specification of therapeutic products. 
 
Leading Companies in the Global Pulmonary Edema Market
 
The report presents a detailed discussion of financial health, recent developments, SWOT analysis, and other information on a variety of industry verticals of some of the key businesses in the market. Also included is a detailed account of activities of medical research universities engaged in research and development activities of pulmonary edema therapeutic products. These include MayoClinic, Synvista Therapeutics includes, Inc., University of Heidelberg, Hopitaux Universitaires de Gene ve, and University of Oxford, among others. 

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=2250<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Discover the Growth of the Pulmonary edema Market 2019 here

News-ID: 877475 • Views: 127

More Releases from Transparency Market Research

Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It
OEM Insulation Market Growth, Trends and Value Chain 2019-2027 by TMR
OEM Insulation Market – Overview OEM means Original Equipment Manufacturer that indicates to a company that produces a part or a subsystem of a product that is being used by another organization. Thermal insulation or simply insulation allows the product to cut down the heat gain or loss at the minimum by creating a barrier between the surfaces at the varying temperatures. There are wide range of applications and end-use verticals

All 5 Releases


More Releases for Pulmonary

Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
Global Pulmonary Arterial Hypertension Market to 2024
Global Pulmonary Arterial Hypertension (PAH) market was valued at $5.0bn in 2015 and is forecast to grow at a modest 6.0% CAGR between 2015 and 2024, to result in 2024 global sales of $9.0bn. PAH is broadly split into two classes, primary or secondary. Primary pulmonary hypertension (PPH) refers to pulmonary hypertension occurring without an identifiable cause. Secondary pulmonary arterial hypertension (PAH) occurs in association with some other identifiable medical condition.
Pulmonary Fibrosis Market Professional Survey Report 2017
Global Pulmonary Fibrosis Market: Snapshot Pulmonary fibrosis belongs to the family of interstitial diseases that can lead to damage of the lungs. As the lung tissue becomes stiff and thickened, it interferes with a person’s ability to breathe. The scarring of lung tissues is associated with a multitude of factors. However, in most cases, the cause of the problem can’t be determined. This state is termed as idiopathic pulmonary fibrosis. While the
Pulmonary Drugs 2024 Market Research Report
Global Pulmonary Drugs Market: Snapshot The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in
Latest Report: Global Pulmonary Hypertension Market
MarketResearchReports.Biz presents this most up-to-date research on "Pulmonary Hypertension-Pipeline Insights, 2017" DelveInsights, Pulmonary Hypertension-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Pulmonary Hypertension. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations,